NCT03661021

Brief Summary

Sante Fe is an investigation of a new technique to distinguish between different types of movement disorders, specifically organic versus functional, by observing changes in involuntary movements in two different situations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 18, 2018

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

August 9, 2018

Completed
29 days until next milestone

First Posted

Study publicly available on registry

September 7, 2018

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2024

Completed
Last Updated

February 13, 2025

Status Verified

August 1, 2024

Enrollment Period

6 years

First QC Date

August 9, 2018

Last Update Submit

February 11, 2025

Conditions

Keywords

Functional movement disorderFunctional neurological disorderFMDPsychogenic movement disorderMovement Disorders

Outcome Measures

Primary Outcomes (1)

  • Change in Simplified Functional Movement Disorders Rating Scale (sFMDRS) score according to video raters between two conditions in FMD vs OrgMD patients.

    Change in Simplified Functional Movement Disorders Rating Scale (sFMDRS) score according to video raters between two conditions in FMD vs OrgMD patients. Score reports total abnormal movement score ranging from 0-3 for 9 different regions of the body or body functions. Higher score implies more severe movement.

    Because this is a one-time visit study, outcome will be measured during the visit, data reported at study conclusion after successfully recruiting 40 subjects and completing analysis with projected finish date in 1 year

Secondary Outcomes (1)

  • The difference in the numerical change in self-perception of movement severity between two conditions in FMD vs OrgMD patients

    Because this is a one-time visit study, outcome will be measured during the visit, data reported at study conclusion after successfully recruiting 40 subjects and completing analysis with projected finish date in 1 year

Other Outcomes (3)

  • Correlation between severity of depression or anxiety using PHQ-SADS scale and degree of change in severity of abnormal movement

    Because this is a one-time visit study, outcome will be measured during the visit, data reported at study conclusion after successfully recruiting 40 subjects and completing analysis with projected finish date in 1 year

  • Correlation between health care utilization using Health Care Utilization scale and degree of change in severity of abnormal movement

    Because this is a one-time visit study, outcome will be measured during the visit, data reported at study conclusion after successfully recruiting 40 subjects and completing analysis with projected finish date in 1 year

  • Correlation between illness belief/diagnosis agreement using B-IPQ and Agreement with Diagnosis scales and degree of change in severity of abnormal movement

    Because this is a one-time visit study, outcome will be measured during the visit, data reported at study conclusion after successfully recruiting 40 subjects and completing analysis with projected finish date in 1 year

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with Functional or Organic movement disorders at Cleveland Clinic Center for Neurological Restoration

You may qualify if:

  • Patients with a clinical diagnosis of Functional Movement Disorder (e.g. functional tremor, functional dystonia, functional myoclonus) based on Fahn-Williams criteria or OrgMD (e.g. Parkinson disease, essential tremor, cervical dystonia) evaluated by a fellowship-trained movement disorder neurologist at Cleveland Clinic
  • Patients with mild to severe involuntary movement as a result of the movement disorder, visible for video-recording.

You may not qualify if:

  • Significant cognitive impairment that prevents proper informed consent
  • Patients whose movement disorders cannot be captured on video

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Related Publications (9)

  • Hinson VK, Haren WB. Psychogenic movement disorders. Lancet Neurol. 2006 Aug;5(8):695-700. doi: 10.1016/S1474-4422(06)70523-3.

    PMID: 16857575BACKGROUND
  • Voon V, Brezing C, Gallea C, Ameli R, Roelofs K, LaFrance WC Jr, Hallett M. Emotional stimuli and motor conversion disorder. Brain. 2010 May;133(Pt 5):1526-36. doi: 10.1093/brain/awq054. Epub 2010 Apr 5.

    PMID: 20371508BACKGROUND
  • van Poppelen D, Saifee TA, Schwingenschuh P, Katschnig P, Bhatia KP, Tijssen MA, Edwards MJ. Attention to self in psychogenic tremor. Mov Disord. 2011 Dec;26(14):2575-6. doi: 10.1002/mds.23911. Epub 2011 Oct 24. No abstract available.

    PMID: 22025317BACKGROUND
  • de Lange FP, Roelofs K, Toni I. Increased self-monitoring during imagined movements in conversion paralysis. Neuropsychologia. 2007 May 15;45(9):2051-8. doi: 10.1016/j.neuropsychologia.2007.02.002. Epub 2007 Feb 11.

    PMID: 17367826BACKGROUND
  • Sitek EJ, Slawek J, Wieczorek D. [Self-awareness of deficits in Huntington's and Parkinson's disease]. Psychiatr Pol. 2008 May-Jun;42(3):393-403. Polish.

    PMID: 19899567BACKGROUND
  • Amanzio M, Monteverdi S, Giordano A, Soliveri P, Filippi P, Geminiani G. Impaired awareness of movement disorders in Parkinson's disease. Brain Cogn. 2010 Apr;72(3):337-46. doi: 10.1016/j.bandc.2009.10.011. Epub 2009 Nov 14.

    PMID: 19914762BACKGROUND
  • Straumann C, Anderson JR. Mirror-induced social facilitation in stumptailed macaques (Macaca arctoides). Am J Primatol. 1991;25(2):125-132. doi: 10.1002/ajp.1350250206.

    PMID: 31948184BACKGROUND
  • Landers DM, McCullagh PD. Social facilitation of motor performance. Exerc Sport Sci Rev. 1976;4:125-62. No abstract available.

    PMID: 798687BACKGROUND
  • Nielsen G, Ricciardi L, Meppelink AM, Holt K, Teodoro T, Edwards M. A Simplified Version of the Psychogenic Movement Disorders Rating Scale: The Simplified Functional Movement Disorders Rating Scale (S-FMDRS). Mov Disord Clin Pract. 2017 Mar 11;4(5):710-716. doi: 10.1002/mdc3.12475. eCollection 2017 Sep-Oct.

    PMID: 30363505BACKGROUND

MeSH Terms

Conditions

Conversion DisorderMovement Disorders

Condition Hierarchy (Ancestors)

Somatoform DisordersMental DisordersCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Xin Xin Yu, MD

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician

Study Record Dates

First Submitted

August 9, 2018

First Posted

September 7, 2018

Study Start

July 18, 2018

Primary Completion

July 22, 2024

Study Completion

July 22, 2024

Last Updated

February 13, 2025

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations